Start with why your GLP-1 was prescribed. If it's for a use that Medicare Part D can cover, check with your drug plan about that exact product. If it's solely for weight management, the Medicare GLP-1 Bridge may cover certain products for $50 a month if you meet the program's requirements.
The Bridge began July 1, 2026. As of November 20, 2026, the Centers for Medicare & Medicaid Services (CMS) lists December 31, 2027 as its end date. It uses a separate approval and payment process from your Part D plan. CMS Medicare GLP-1 Bridge overview
Should your prescription go to Part D or the Bridge?
| Why you're being prescribed a GLP-1 | Where to start |
|---|---|
| Type 2 diabetes, an approved use such as Zepbound for moderate-to-severe obstructive sleep apnea in an adult with obesity, or Wegovy injection for qualifying noncirrhotic MASH | Ask your prescriber and Part D plan about the exact product and diagnosis. CMS excludes these diagnoses from Bridge access. |
| Reducing the risk of major cardiovascular events, such as Wegovy for an adult with established cardiovascular disease and overweight or obesity | Start with Part D, even if weight management is another goal. |
| Weight management alone | Check Bridge plan type, clinical criteria, product form, and prior coverage. |
Having a history of heart attack or stroke can count toward a Bridge eligibility criterion for a prescription solely for weight management. A Wegovy prescription written to reduce cardiovascular risk uses the Part D route. A Part D plan may have its own formulary and prior authorization rules. If the prescription is for a Part D-covered use, ask about those rules or an exception even if the plan doesn't list the drug. CMS instructions for Part D plans · Wegovy U.S. prescribing information
If you already filled a GLP-1 through your Part D plan in 2026, CMS says to keep using that route for 2026, including if your plan covered weight management as a supplemental benefit. For a new plan year, check your current benefit and CMS instructions. CMS instructions for Part D plans
Could you qualify for the Medicare GLP-1 Bridge?
You must be at least 18 and have an eligible drug plan, such as a standalone Part D prescription drug plan or an eligible Medicare Advantage plan with drug coverage. Certain plan types, including PACE and private fee-for-service, generally don't qualify unless you also have standalone Part D enrollment where applicable. Your prescriber must attest that the prescription is for weight management alongside a structured nutrition and physical activity program consistent with the product label. CMS provider criteria
| BMI when you began GLP-1 treatment | Which additional condition is required? |
|---|---|
| 35 or higher | None for this BMI tier |
| 30 or higher | Heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or higher |
| 27 or higher | Prediabetes under American Diabetes Association criteria, prior heart attack, prior stroke, or symptomatic peripheral artery disease |
For the hypertension criterion, CMS requires systolic pressure above 140 mm Hg or diastolic pressure above 90 mm Hg while taking two blood pressure medications at the same time. If you started GLP-1 therapy before Medicare or before the Bridge opened, CMS still uses the clinical criteria at the start of treatment. If your BMI went from 36 to 33, for example, ask the first prescriber for the chart or records documenting your starting BMI. You can check your plan type and other requirements in Medicare's beneficiary eligibility guide or call 1-800-MEDICARE.
Is the exact form you use on the Bridge list?
CMS currently lists Foundayo tablets, Wegovy injection and tablets, and Zepbound KwikPen. Single-dose Zepbound pens and single-dose vials are excluded. Ask your pharmacy to confirm the presentation and its exact National Drug Code against the current list. This matters if a claim fails even though the brand name looks right. CMS covered forms and codes
Who files for Bridge coverage, and in what order?
You can start with your prescriber and pharmacy. A commercial membership or a Part D denial is unnecessary. CMS prior authorization instructions for providers
- Prescriber sends the prescription. Bring the drug plan information, exact drug and form, why you take it, and any starting BMI and diagnosis records. Ask the prescriber to tell the pharmacy if the prescription should go to the Bridge.
- Pharmacy sends the Bridge claim. Once the pharmacy submits the claim and sees that prior authorization is needed, it usually sends a request to the prescriber within 24 to 72 hours.
- Prescriber submits the authorization. If no request arrives within 72 hours of the pharmacy's claim establishing the need for authorization, the prescriber can use the fax form in the CMS provider instructions.
- Check the decision and processed price. CMS sends the decision to you by mail and to the prescriber electronically or by fax. Medicare says an approval runs through December 31, 2027, including refills and dose changes, unless you switch GLP-1 medicines. Ask about authorization before a switch. Medicare beneficiary guide
What should you do if the prescription gets stuck or denied?
- “Patient not found.” Ask the pharmacy whether it sent the Bridge claim before the prescriber tried to file authorization. CMS says starting with the authorization can cause that error.
- “We're waiting on the office.” Ask for the date the pharmacy sent the claim and when it sent the authorization request. Share that date with the office so it can tell whether the CMS form is needed.
- “Denied.” Ask for the written reason and which route made the decision. The Bridge allows the prescriber to resubmit corrected or additional information and has no appeal process. For a regular Part D denial, ask the plan about a coverage determination, exception, or appeal. CMS Bridge provider instructions · Medicare drug plan appeals
What does the $50 copay cover?
The $50 is for the Bridge medication. The Part D deductible does not apply to it, it does not count toward Part D out-of-pocket spending, and Part D Extra Help does not reduce it. Office visits and any optional services are separate expenses. CMS also says Zepbound KwikPen needles are purchased separately. CMS Bridge payment rules · CMS provider FAQ on pen needles
Keep a note of your exact drug form, the coverage route, the approval and its end date. CMS says the BALANCE model will not start in Medicare Part D in 2027. Check for new CMS information before planning refills past the current Bridge end date. If access may change sooner, ask your prescriber while you still have time to discuss your options. For other costs, see how to calculate your GLP-1 cost with insurance.

About the author
Maya Lee
Glowise Senior GLP-1 Content Editor
Maya Lee is a Glowise Health Content Editor. Her guides turn product records, authoritative sources, and everyday organization questions into clear, practical GLP-1 information.
She helps readers ask better questions and keep the details relevant to a care conversation together.
See more Glowise on Google
Add Glowise as a preferred source to find our GLP-1 guides more easily in Google Search.


